By combining genetic studies in over 0.5 million people with detailed functional characterization of identified MC4R variants in cells, we demonstrated that β-arrestin-biased GoF MC4R variants are associated with lower risk of obesity and its cardio-metabolic complications in the general population. Here, MC4R is linked to Obesity.